Influenza Virus Assays Based on Virus-inducible Reporter Cell Lines

Overview

Journal Influenza Other Respir Viruses

Publisher Wiley

Specialty Microbiology

Date 2011 Apr 5

PMID 21462401

Citations 7

Authors

Yunsheng Li

Audrey Larrimer

Teresa Curtiss

Jaekyung Kim

Abby Jones

Heather Baird-Tomlinson

Andrew Pekosz

Paul D Olivo

Affiliations

Soon will be listed here.

Abstract

Background: Virus-inducible reporter genes have been used as the basis of virus detection and quantitation assays for a number of viruses. A strategy for influenza A virus-induction of a reporter gene was recently described. In this report, we describe the extension of this strategy to influenza B virus, the generation of stable cell lines with influenza A and B virus-inducible reporter genes, and the use of these cells in various clinically relevant viral assays. Each of the cell lines described herein constitutively express an RNA transcript that contains a reporter gene coding region flanked by viral 5￠- and 3￠-untranslated regions (UTR) and therefore mimics an influenza virus genomic segment. Upon infection of the cells with influenza virus the virus-inducible reporter gene segment (VIRGS) is replicated and transcribed by the viral polymerase complex resulting in reporter gene expression.

Findings: Reporter gene induction occurs after infection with a number of laboratory strains and clinical isolates of influenza virus including several H5N1 strains. The induction is dose-dependent and highly specific for influenza A or influenza B viruses.

Conclusions: These cell lines provide the basis of simple, rapid, and objective assays that involve virus quantitation such as determination of viral titer, assessment of antiviral susceptibility, and determination of antibody neutralization titer. These cell lines could be very useful for influenza virus researchers and vaccine manufacturers.

Citing Articles

Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation.

Din G, Wu C, Tariq Z, Hasham K, Amjad M, Shen B Virol J. 2024; 21(1):196.

PMID: 39180083 PMC: 11344405. DOI: 10.1186/s12985-024-02433-8.

High-Throughput cell-based immunofluorescence assays against influenza.

Martinez-Gzegozewska Y, Rasmussen L, McKellip S, Manuvakhova A, Nebane N, Reece A SLAS Discov. 2023; 29(1):66-76.

PMID: 37925159 PMC: 10859970. DOI: 10.1016/j.slasd.2023.10.008.

A Comprehensive Roadmap Towards the Generation of an Influenza B Reporter Assay Using a Single DNA Polymerase-Based Cloning of the Reporter RNA Construct.

Kedia N, Banerjee S, Mondal A Front Microbiol. 2022; 13:868367.

PMID: 35694292 PMC: 9174941. DOI: 10.3389/fmicb.2022.868367.

Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators.

Harfoot R, Yung D, Anderson W, Wild C, Coetzee N, Hernandez L Pathogens. 2022; 11(1).

PMID: 35056031 PMC: 8780977. DOI: 10.3390/pathogens11010083.

Cell Cultures for Virology: Usability, Advantages, and Prospects.

Dolskiy A, Grishchenko I, Yudkin D Int J Mol Sci. 2020; 21(21).

PMID: 33121109 PMC: 7662242. DOI: 10.3390/ijms21217978.

References

Stabell E, ORourke S, Storch G, Olivo P . Evaluation of a genetically engineered cell line and a histochemical beta-galactosidase assay to detect herpes simplex virus in clinical specimens. J Clin Microbiol. 1993; 31(10):2796-8. PMC: 266019. DOI: 10.1128/jcm.31.10.2796-2798.1993. View

Stephenson I, Das R, Wood J, Katz J . Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine. 2007; 25(20):4056-63. DOI: 10.1016/j.vaccine.2007.02.039. View

. Update: influenza activity - United States, September 28, 2008--January 31, 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(5):115-9. View

Noah J, Severson W, Noah D, Rasmussen L, White E, Jonsson C . A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res. 2006; 73(1):50-9. DOI: 10.1016/j.antiviral.2006.07.006. View

Ochiai H, Sakai S, Hirabayashi T, Shimizu Y, Terasawa K . Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells. Antiviral Res. 1995; 27(4):425-30. DOI: 10.1016/0166-3542(95)00040-s. View

Zobel A, Neumann G, HOBOM G . RNA polymerase I catalysed transcription of insert viral cDNA. Nucleic Acids Res. 1993; 21(16):3607-14. PMC: 309854. DOI: 10.1093/nar/21.16.3607. View

Wetherall N, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin J, Zambon M . Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol. 2003; 41(2):742-50. PMC: 149673. DOI: 10.1128/JCM.41.2.742-750.2003. View

Lipsitch M, Cohen T, Murray M, Levin B . Antiviral resistance and the control of pandemic influenza. PLoS Med. 2007; 4(1):e15. PMC: 1779817. DOI: 10.1371/journal.pmed.0040015. View

Olivo P, Frolov I, Schlesinger S . A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses. Virology. 1994; 198(1):381-4. DOI: 10.1006/viro.1994.1046. View

10.

Simonsen L, Reichert T, Viboud C, Blackwelder W, Taylor R, Miller M . Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005; 165(3):265-72. DOI: 10.1001/archinte.165.3.265. View

11.

. Update: infections with a swine-origin influenza A (H1N1) virus--United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(16):431-3. View

12.

Wu W, Pekosz A . Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro. J Virol. 2007; 82(2):1059-63. PMC: 2224589. DOI: 10.1128/JVI.01499-07. View

13.

Molinari N, Ortega-Sanchez I, Messonnier M, Thompson W, Wortley P, Weintraub E . The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25(27):5086-96. DOI: 10.1016/j.vaccine.2007.03.046. View

14.

Frank A, Puck J, Hughes B, CATE T . Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol. 1980; 12(3):426-32. PMC: 273601. DOI: 10.1128/jcm.12.3.426-432.1980. View

15.

Bachmann M, Ecabert B, Kopf M . Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro. J Immunol Methods. 1999; 225(1-2):105-11. DOI: 10.1016/s0022-1759(99)00034-4. View

16.

Lutz A, Dyall J, Olivo P, Pekosz A . Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods. 2005; 126(1-2):13-20. PMC: 1698269. DOI: 10.1016/j.jviromet.2005.01.016. View

17.

Proffitt M, Schindler S . Rapid detection of HSV with an enzyme-linked virus inducible system (ELVIS) employing a genetically modified cell line. Clin Diagn Virol. 1995; 4(2):175-82. DOI: 10.1016/0928-0197(95)00011-v. View

18.

Tobita K, Sugiura A, Enomote C, Furuyama M . Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol. 1975; 162(1):9-14. DOI: 10.1007/BF02123572. View

19.

Bacheler L, Strehl L, Neubauer R, Petteway Jr S, Ferguson B . Stable indicator cell lines exhibiting HIV-1 tat function. AIDS Res Hum Retroviruses. 1989; 5(3):275-8. DOI: 10.1089/aid.1989.5.275. View

20.

Kiseleva I, Su Q, Toner T, Szymkowiak C, Kwan W, Rudenko L . Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses. J Virol Methods. 2004; 116(1):71-8. DOI: 10.1016/j.jviromet.2003.10.012. View